The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
Open accessAbstract
Dendritic cells (DCs) are the sentinel antigen-presenting cells of the immune system; such that their productive interface with the dying cancer cells is crucial for proper communication of the "non-self" status of cancer cells to the adaptive immune system. Efficiency and the ultimate success of such a communication hinges upon the maturation status of the DCs, attained following their interaction with cancer cells. Immature DCs facilitate tolerance toward cancer cells (observed for many apoptotic inducers) while fully mature DCs can strongly promote anticancer immunity if they secrete the correct combinations of cytokines [observed when DCs interact with cancer cells undergoing immunogenic cell death (ICD)]. However, an intermediate population of DC maturation, called semi-mature DCs exists, which can potentiate either tolerogenicity or pro-tumorigenic responses (as happens in the case of certain chemotherapeutics and agents exerting ambivalent immune reactions). Specific combinations of DC phenotypic markers, DC-derived cytokines/chemokines, dying cancer cell-derived danger signals, and other less characterized entities (e.g., exosomes) can define the nature and evolution of the DC maturation state. In the present review, we discuss these different maturation states of DCs, how they might be attained and which anticancer agents or cell death modalities (e.g., tolerogenic cell death vs. ICD) may regulate these states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 7×
“, the innate immune system and the adaptive immune system (1, 2).”
BackgroundMethodInfluentialSipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572 · cited 1×
“The Phase III clinical trial revealed increased overall survival of patients treated with Provenge in comparison to placebo (86, 87).”
BackgroundThe Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Self-citationCalreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Harding, C., Heuser, J., & Stahl, P. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.2.329 · Cited by 1,775 · cited 1×
“Historically, exosomes were classified as a simple mechanism for the removal of unwanted cellular material (92, 93), yet more recently they have been implicated in the transmission of signals between cells, both locally and over”
BackgroundT-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
Mempel, T. R., Henrickson, S. E., & von Andrian, U. H. (2004) · Nature · doi:10.1038/nature02238 · Cited by 1,714
Combining immunotherapy and targeted therapies in cancer treatment
Vanneman, M., & Dranoff, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3237 · Cited by 1,586
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349
Pan, B. T., Teng, K., Wu, C., Adam, M., & Johnstone, R. M. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.942 · Cited by 1,241
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
Admyre, C., Johansson, S. M., Qazi, K. R., Filén, J.-J., Lahesmaa, R., Norman, M., Neve, E. P. A., Scheynius, A., & Gabrielsson, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1969 · Cited by 1,217
Dendritic cells in a mature age
Reis e Sousa, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1845 · Cited by 1,195
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,074
Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.-P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40483 · Cited by 998
Malignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953
Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages
Lässer, C., Seyed Alikhani, V., Ekström, K., Eldh, M., Torregrosa Paredes, P., Bossios, A., Sjöstrand, M., Gabrielsson, S., Lötvall, J., & Valadi, H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-9 · Cited by 899
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
Sokolova, V., Ludwig, A.-K., Hornung, S., Rotan, O., Horn, P. A., Epple, M., & Giebel, B. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.05.013 · Cited by 851
Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Self-citationWalter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2883 · Cited by 788
Boni, A., Cogdill, A. P., Dang, P., Udayakumar, D., Njauw, C.-N. J., Sloss, C. M., Ferrone, C. R., Flaherty, K. T., Lawrence, D. P., Fisher, D. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0118 · Cited by 742
Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., & Multhoff, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3804 · Cited by 695
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V., & Amigorena, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.018 · Cited by 676
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2742 · Cited by 624
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Janssen, E. M., Droin, N. M., Lemmens, E. E., Pinkoski, M. J., Bensinger, S. J., Ehst, B. D., Griffith, T. S., Green, D. R., & Schoenberger, S. P. (2005) · Nature · doi:10.1038/nature03337 · Cited by 619
Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies
Subra, C., Laulagnier, K., Perret, B., & Record, M. (2007) · Biochimie · doi:10.1016/j.biochi.2006.10.014 · Cited by 619
ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
Segura, E., Nicco, C., Lombard, B., Véron, P., Raposo, G., Batteux, F., Amigorena, S., & Théry, C. (2005) · Blood · doi:10.1182/blood-2005-01-0220 · Cited by 613
Maximizing Tumor Immunity With Fractionated Radiation
Schaue, D., Ratikan, J. A., Iwamoto, K. S., & McBride, W. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.049 · Cited by 567
Exosomes: Small vesicles participating in intercellular communication
Ludwig, A.-K., & Giebel, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.005 · Cited by 537
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q., de Ruiter, P. E., Willemsen, R., Demmers, J. A. A., Stalin Raj, V., Jenster, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221899110 · Cited by 502
Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
Garg, A. D., Nowis, D., Golab, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 496
Self-citationTolerogenic dendritic cells: cytokine modulation comes of age
Rutella, S., Danese, S., & Leone, G. (2006) · Blood · doi:10.1182/blood-2006-03-006403 · Cited by 491
Tumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
MacLeod (2008) · Bristol Research (University of Bristol) · doi:10.4049/jimmunol · Cited by 448
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Gupta, A., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita, H., Schwendener, R., Pruschy, M., Knuth, A., & van den Broek, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446
Viaud, S., Terme, M., Flament, C., Taieb, J., André, F., Novault, S., Escudier, B., Robert, C., Caillat-Zucman, S., Tursz, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004942 · Cited by 437
Activated T cells recruit exosomes secreted by dendritic cells via LFA-1
Nolte-‘t Hoen, E. N. M., Buschow, S. I., Anderton, S. M., Stoorvogel, W., & Wauben, M. H. M. (2009) · Blood · doi:10.1182/blood-2008-08-174094 · Cited by 436
Miller, M. J., Hejazi, A. S., Wei, S. H., Cahalan, M. D., & Parker, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306407101 · Cited by 436
Tumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425
ER stress-induced inflammation: does it aid or impede disease progression?
Garg, A. D., Kaczmarek, A., Krysko, O., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.010 · Cited by 420
Self-citationMartins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2011) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 414
Henrickson, S. E., Mempel, T. R., Mazo, I. B., Liu, B., Artyomov, M. N., Zheng, H., Peixoto, A., Flynn, M. P., Senman, B., Junt, T., et al. (2008) · Nature Immunology · doi:10.1038/ni1559 · Cited by 394
Admyre, C., Grunewald, J., Thyberg, J., Gripenbäck, S., Tornling, G., Eklund, A., Scheynius, A., & Gabrielsson, S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00041703 · Cited by 383
Schiavoni, G., Sistigu, A., Valentini, M., Mattei, F., Sestili, P., Spadaro, F., Sanchez, M., Lorenzi, S., D'Urso, M. T., Belardelli, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2788 · Cited by 362
Dendritic Cells in the Cancer Microenvironment
Ma, Y., Shurin, G. V., Peiyuan, Z., & Shurin, M. R. (2013) · Journal of Cancer · doi:10.7150/jca.5046 · Cited by 361
Munich, S., Sobo-Vujanovic, A., Buchser, W. J., Beer-Stolz, D., & Vujanovic, N. L. (2012) · OncoImmunology · doi:10.4161/onci.20897 · Cited by 360
Toll-like receptors and dendritic cells: for whom the bug tolls
Reis e Sousa, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.004 · Cited by 341
Lesterhuis, W. J., Punt, C. J. A., Hato, S. V., Eleveld-Trancikova, D., Jansen, B. J. H., Nierkens, S., Schreibelt, G., de Boer, A., Van Herpen, C. M. L., Kaanders, J. H., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43656 · Cited by 340
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apetoh, L., Ghiringhelli, F., Casares, N., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100269 · Cited by 337
Engelhardt, J. J., Boldajipour, B., Beemiller, P., Pandurangi, P., Sorensen, C., Werb, Z., Egeblad, M., & Krummel, M. F. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.008 · Cited by 330
Dendritic Cells: Master Regulators of the Immune Response
Mellman, I. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0102 · Cited by 329
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
Garg, A. D., Dudek, A. M., Ferreira, G. B., Verfaillie, T., Vandenabeele, P., Krysko, D. V., Mathieu, C., & Agostinis, P. (2013) · Autophagy · doi:10.4161/auto.25399 · Cited by 305
Self-citationSegura, E., Amigorena, S., & Théry, C. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2005.05.003 · Cited by 300
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1184-2 · Cited by 292
Self-citationZeelenberg, I. S., Ostrowski, M., Krumeich, S., Bobrie, A., Jancic, C., Boissonnas, A., Delcayre, A., Le Pecq, J.-B., Combadière, B., Amigorena, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3163 · Cited by 286
Hodge, J. W., Garnett, C. T., Farsaci, B., Palena, C., Tsang, K., Ferrone, S., & Gameiro, S. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.28070 · Cited by 281
Autophagy: shaping the tumor microenvironment and therapeutic response
Maes, H., Rubio, N., Garg, A. D., & Agostinis, P. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.04.005 · Cited by 268
Self-citationDubensky, T. W., & Reed, S. G. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.04.007 · Cited by 259
Antigen-loaded exosomes alone induce Th1-type memory through a B cell–dependent mechanism
Qazi, K. R., Gehrmann, U., Domange Jordö, E., Karlsson, M. C. I., & Gabrielsson, S. (2009) · Blood · doi:10.1182/blood-2008-04-153536 · Cited by 250
Inducers of immunogenic cancer cell death
Dudek, A. M., Garg, A. D., Krysko, D. V., De Ruysscher, D., & Agostinis, P. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.01.005 · Cited by 250
Self-citationTrial watch: Dendritic cell-based interventions for cancer therapy
Vacchelli, E., Vitale, I., Eggermont, A., Fridman, W. H., Fučíková, J., Cremer, I., Galon, J., Tartour, E., Zitvogel, L., Kroemer, G., et al. (2013) · OncoImmunology · doi:10.4161/onci.25771 · Cited by 247
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Kruit, W. H. J., Suciu, S., Dreno, B., Mortier, L., Robert, C., Chiarion-Sileni, V., Maio, M., Testori, A., Dorval, T., Grob, J.-J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.7111 · Cited by 227
Danger signalling during cancer cell death: origins, plasticity and regulation
Garg, A. D., Martin, S., Golab, J., & Agostinis, P. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.48 · Cited by 226
Self-citationHosseini-Beheshti, E., Pham, S., Adomat, H., Li, N., & Tomlinson Guns, E. S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014845 · Cited by 224
Features of the dendritic cell lineage
Steinman, R. M., & Idoyaga, J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00888.x · Cited by 215
A Perspective on Mammalian Caspases as Positive and Negative Regulators of Inflammation
Martin, S. J., Henry, C. M., & Cullen, S. P. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.026 · Cited by 205
Self-citationKotera, Y., Shimizu, K., & Mulé, J. J. (2001) · PubMed · Cited by 204
Dendritic Cell–Derived Exosomes Need To Activate Both T and B Cells To Induce Antitumor Immunity
Näslund, T. I., Gehrmann, U., Qazi, K. R., Karlsson, M. C. I., & Gabrielsson, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203082 · Cited by 203
Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines
Taieb, J., Chaput, N., Schartz, N., Roux, S., Novault, S., Ménard, C., Ghiringhelli, F., Terme, M., Carpentier, A. F., Darrasse-Jèse, G., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2722 · Cited by 200
Measles virus causes immunogenic cell death in human melanoma
Donnelly, O. G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V, Scott, K., Peach, H., Phillips, R. M., Bond, J., Pandha, H., et al. (2013) · Gene Therapy · doi:10.1038/gt.2011.205 · Cited by 187
Simmons, D. P., Wearsch, P. A., Canaday, D. H., Meyerson, H. J., Liu, Y. C., Wang, Y., Boom, W. H., & Harding, C. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101313 · Cited by 185
Speetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2227 · Cited by 185
Indoleamine 2,3-Dioxygenase and Dendritic Cell Tolerogenicity
Harden, J. L., & Egilmez, N. K. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.676122 · Cited by 176
Trial watch: Dendritic cell-based interventions for cancer therapy
Galluzzi, L., Senovilla, L., Vacchelli, E., Eggermont, A. M. M., Fridman, W. H., Galon, J., Sautès‐Fridman, C., Tartour, É., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.21494 · Cited by 173
Dendritic cell derived-exosomes: biology and clinical implementations
Chaput, N., Flament, C., Viaud, S., Taïeb, J., Roux, S., Spatz, A., André, F., Pecq, J. L., Boussac, M., Garin, J., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206094 · Cited by 160
Leffers, N., Lambeck, A. J. A., Gooden, M. J. M., Hoogeboom, B. N., Wolf, R., Hamming, I. L. E., Hepkema, B. G., Willemse, P. H. B., Molmans, B. H. W., Hollema, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24597 · Cited by 156
Prasad, S. J., Farrand, K. J., Matthews, S. A., Chang, J. H., McHugh, R. S., & Ronchese, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.90 · Cited by 153
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome, S. E., Voss, S. G., Wilcox, R. A., Wakefield, T. L., Tamada, K., Flies, D. B., Chapoval, A. I., Lu, J., Kasperbauer, J. L., Padley, D. J., et al. (2002) · PubMed · Cited by 153
Barratt‐Boyes, S. M., Zimmer, M. I., Harshyne, L. A., Meyer, E. M., Watkins, S. C., Capuano, S., Murphey‐Corb, M., Falo, L. D., & Donnenberg, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2487 · Cited by 151
Henrickson, S. E., Perro, M., Loughhead, S. M., Senman, B. C., Stutte, S., Quigley, M. M., Alexe, G., Iannacone, M., Flynn, M. P., Omid, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.034 · Cited by 145
Lu, G., Janjic, B. M., Janjic, J. M., Whiteside, T. L., Storkus, W. J., & Vujanović, N. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1831 · Cited by 140
Speiser, D. E., Baumgaertner, P., Voelter, V., Devêvre, E., Barbey, C., Rufer, N., & Romero, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800080105 · Cited by 137
Gehrmann, U., Hiltbrunner, S., Georgoudaki, A., Karlsson, M. C. I., Näslund, T. I., & Gabrielsson, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3918 · Cited by 137
Immunotherapy: Bewitched, Bothered, and Bewildered No More
Steinman, R. M., & Mellman, I. (2004) · Science · doi:10.1126/science.1099688 · Cited by 136
Nakahara, T., Uchi, H., Lesokhin, A. M., Avogadri, F., Rizzuto, G. A., Hirschhorn-Cymerman, D., Panageas, K. S., Merghoub, T., Wolchok, J. D., & Houghton, A. N. (2010) · Blood · doi:10.1182/blood-2009-11-251231 · Cited by 134
Hao, S., Bai, O., Yuan, J., Qureshi, M., & Xiang, J. (2006) · PubMed · Cited by 132
Bugaut, H., Bruchard, M., Berger, H., Dérangère, V., Odoul, L., Euvrard, R., Ladoire, S., Chalmin, F., Végran, F., Rébé, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065181 · Cited by 130
Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer
Gabriel, K., Ingram, A. J., Austin, R. C., Kapoor, A., Tang, D., Majeed, F., Qureshi, T. M., & Al-Nedawi, K. N. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070047 · Cited by 129
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · BioFactors · doi:10.1002/biof.1125 · Cited by 128
Self-citationAudia, S., Nicolas, A., Cathelin, D., Larmonier, N., Ferrand, C., Foucher, P., Fanton, A., Bergoin, E., Maynadié, M., Arnould, L., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03521.x · Cited by 123
Salem, M. L., Kadima, A. N., El-Naggar, S. A., Rubinstein, M. P., Chen, Y., Gillanders, W. E., & Cole, D. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211311.28739.e3 · Cited by 119
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Chiang, C. L.-L., Kandalaft, L. E., & Coukos, G. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.572210 · Cited by 119
Cell-derived microvesicles and cancer.
van Doormaal, F. F., Kleinjan, A., Nisio, M. D., Buller, H. R., & Nieuwland, R. (2009) · PubMed · Cited by 117
Salem, M. L., Diaz-Montero, C. M., Al-Khami, A. A., El-Naggar, S. A., Naga, O. S., Montero, A. J., Khafagy, A., & Cole, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801829 · Cited by 115
The emergence of phox-ER stress induced immunogenic apoptosis
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2012) · OncoImmunology · doi:10.4161/onci.19750 · Cited by 110
Self-citationOtt, P. A., Henry, T., Baranda, S. J., Frleta, D., Manches, O., Bogunovic, D., & Bhardwaj, N. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1389-z · Cited by 108
Schneider, T., Hoffmann, H., Dienemann, H., Schnabel, P. A., Enk, A., Ring, S., & Mahnke, K. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821c421d · Cited by 105
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
Martin, F., Apétoh, L., & Ghiringhelli, F. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.007 · Cited by 104
Janjic, B. M., Lu, G., Pimenov, A. A., Whiteside, T. L., Storkus, W. J., & Vujanović, N. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1823 · Cited by 100
Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
Manzoni, M., Rovati, B., Ronzoni, M., Loupakis, F., Mariucci, S., Ricci, V., Gattoni, E., Salvatore, L., Tinelli, C., Villa, E., et al. (2010) · Oncology · doi:10.1159/000320609 · Cited by 97
Why do cells release vesicles?
Nieuwland, R., & Sturk, A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.037 · Cited by 96
Novel MHC Class I Structures on Exosomes
Lynch, S., Santos, S. G., Campbell, E. C., Nimmo, A., Botting, C. H., Prescott, A. R., Antoniou, A. N., & Powis, S. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900798 · Cited by 95
The role of tetraspanin CD63 in antigen presentation via MHC class II
Petersen, S. H., Odintsova, E., Haigh, T. A., Rickinson, A. B., Taylor, G. S., & Berditchevski, F. (2011) · European Journal of Immunology · doi:10.1002/eji.201141438 · Cited by 89
Cirone, M., Renzo, L. D., Lotti, L. V., Conte, V., Trivedi, P., Santarelli, R., Gonnella, R., Frati, L., & Faggioni, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031732 · Cited by 86
Immunosuppressive Exosomes: A New Approach for Treating Arthritis
Yang, C., & Robbins, P. D. (2012) · International Journal of Rheumatology · doi:10.1155/2012/573528 · Cited by 86
Correale, P., Botta, C., Cusi, M. G., Vecchio, M. T. D., Santi, M. M. D., Savellini, G. G., Bestoso, E., Apollinari, S., Mannucci, S., Marra, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26181 · Cited by 77
Filipazzi, P., Pilla, L., Mariani, L., Patuzzo, R., Castelli, C., Camisaschi, C., Maurichi, A., Cova, A., Rigamonti, G., Giardino, F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1516 · Cited by 76
Select forms of tumor cell apoptosis induce dendritic cell maturation
Demaria, S., Santori, F. R., Ng, B., Liebes, L., Formenti, S. C., & Vukmanović, S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804478 · Cited by 71
Yang, D., Park, J., Jin, C.-J., Kang, H., Nam, J., Rhee, J.-H., Kim, Y., Chung, S.-Y., Choi, S.-J.-N., Kim, H., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.006 · Cited by 66
Erratum: TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2011) · Nature reviews. Immunology · doi:10.1038/nri3029 · Cited by 60
Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses
Perrin‐Cocon, L., Agaugué, S., Coutant, F., Saint-Mézard, P., Guironnet‐Paquet, A., Nicolas, J., André, P., & Lotteau, V. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.036 · Cited by 59
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.372 · Cited by 58
Self-citationZumaquero, E., Muñoz, P., Cobo, M., Lucena, G., Pavón, E. J., Algíbez, A. M., Navarro, P., García-Pérez, A., Ariza, A., Malavasi, F., et al. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.032 · Cited by 56
Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ
Iero, M., Valenti, R., Huber, V., et al. (2008) · Cited by 48
Padgett, J. J. (1994) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-19940101-04 · Cited by 47
Moehler, M. H., Sieben, M., Roth, S., Springsguth, F., Leuchs, B., Zeidler, M., Dinsart, C., Rommelaere, J., & Galle, P. R. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-464 · Cited by 42
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · OncoImmunology · doi:10.4161/onci.26260 · Cited by 42
Self-citationRomão, S., Gannagé, M., & Münz, C. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.03.001 · Cited by 42
Guo, F., Chang, C., Fan, H., Nie, X. J., Ren, Y., Liu, Y., & Zhao, L. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600623 · Cited by 42
Quakkelaar, E. D., & Melief, C. J. M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00004-4 · Cited by 41
Killer dendritic cells: IKDC and the others
Bonmort, M., Dalod, M., Mignot, G., Ullrich, E., Chaput, N., & Zitvogel, L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.006 · Cited by 41
Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
Sapoznik, S., Hammer, O., Ortenberg, R., Besser, M. J., Ben-Moshe, T., Schachter, J., & Markel, G. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/818214 · Cited by 37
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
Wen, C.-C., Chen, H., Chen, S.-S., Huang, L., Chang, W., Wei, W., Chou, L., Arulselvan, P., Wu, J., Kuo, S., et al. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-44 · Cited by 36
Ma, B., Jiang, H., Jia, J., Di, L., Song, G., Yu, J., Zhu, Y., Lü, Z., Wang, X., Zhou, X., et al. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0860-9 · Cited by 32
Zheng, J., Liu, Q., Yang, J., Ren, Q., Cao, W. W., Yang, J., Yu, Z., Yu, F., Wu, Y., Shi, H.-J., et al. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500061 · Cited by 30
Huang, J., Wang, Y., Guo, J., Lu, H., Lin, X., Ma, L., Teitz‐Tennenbaum, S., Chang, A. E., & Li, Q. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.02.005 · Cited by 29
Exosomes from CIITA-Transfected CT26 Cells Enhance Anti-tumor Effects
Fan, W. Y., Tian, X.-D., Huang, E., & Zhang, J. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.987 · Cited by 25
Kim, S. K., Yun, C., & Han, S. H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.038 · Cited by 20
Dendritic cell-derived exosomes
Théry, C., Wolfers, J., Régnault, A., André, F., Fernandez, N. C., Raposo, G., Amigorena, S., & Zitvogel, L. (2001) · Elsevier eBooks · doi:10.1016/b978-012455851-9/50052-3 · Cited by 16
Goldberg, J. B. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)01990-4 · Cited by 4
Cited by
Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00347-z · Cited by 1,400
Li, W., Yang, J., Luo, L., Jiang, M., Qin, B., Yin, H., Zhu, C., Yuan, X., Zhang, J., Luo, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11269-8 · Cited by 1,120
Immunogenic cell death in cancer therapy: Present and emerging inducers
Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 719
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
Nastasi, C., Candela, M., Bonefeld, C. M., Geisler, C., Hansen, M., Krejsgaard, T., Biagi, E., Andersen, M. H., Brigidi, P., Ødum, N., et al. (2015) · Scientific Reports · doi:10.1038/srep16148 · Cited by 414
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00588 · Cited by 410
Self-citation
Metadata
- Authors
- Dudek, A. M., Martin, S., Garg, A. D., & Agostinis, P.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 438-438
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2100540383
- Cited by
- 399
- References
- 145
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.